Gesynta Pharma has dosed the first patient in its Phase II trial, NOVA, investigating vipoglanstat, a non-hormonal, ...
Q4 2025 Management View Leiv Lea, Chief Financial Officer, reported research and development expenses of $9.9 million in Q4 2025, attributing the increase to higher clinical trial and manufacturing ...
US-based biopharmaceutical company Spinogenix has concluded the enrolment of patients in its Phase II clinical trial of tazbentetol (previously known as SPG302), a synaptic regenerative treatment for ...
The Chinese biotech put the idea to the test in a phase 2 trial of a subcutaneous depot formulation of its GLP-1 receptor agonist ASC30. U.S. investigators randomized 65 people with obesity or who ...
The 2026 European Association of Urology (EAU) annual meeting featured an advancements in metastatic castration resistant prostate cancer (mCRPC) therapy session and a presentation by Dr. Giulio ...
Winter is Coming on MSN
What could "Phase 2" mean for the Vaults in Fallout season 3?
Let us speculate what Vault-Tec has got cooking for Fallout season 3!
Medicus Pharma (NASDAQ:MDCX) said on Monday that new analysis of data from a mid-stage clinical trial of its SkinJect ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results